GeneReach Biotechnology Corp.

4171

TW0004171004

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
31.95 ^TWD	+0.47%		+5.10%	-19.01%

Mar. 28	GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

GeneReach Biotechnology Corp.(TPEX:4171) dropped from S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about GeneReach Biotechnology Corp.

GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
GeneReach Biotechnology Corp.(TPEX:4171) dropped from S&P Global BMI Index	23-09-18	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-09	CI
GeneReach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-21	CI
Taiwan's OBI Pharma Grants Experimental Drug Rights to Odeon Therapeutics (Hong Kong)	22-02-24	MT
GeneReach Biotechnology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-11	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-09	CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-29	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-10	CI
GeneReach Biotechnology Corp.(GTSM:4171) added to S&P Global BMI Index	20-09-21	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-14	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-29	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-13	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-12	CI
Genereach Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-14	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-29	CI
Genereach Biotechnology Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2018	18-11-12	CI

Chart GeneReach Biotechnology Corp.

Duration

Period

More charts

GeneReach Biotechnology Corp. is principally engaged in the manufacture and distribution of animal testing equipment and testing agents. The Company mainly operates through Taiwan segment. The Company provides shrimp virus testing agents, on-site detection systems for fish and shrimp, mini centrifugal machines, pet disease testing agents and other testing equipment.

Sector

Pharmaceuticals

More about the company